Specific gene suppression using antisense strategy for growth suppression of glioma

Akira Matsuno1, Tadashi Nagashima

  • 1Department of Neurosurgery, Teikyo University Ichihara Hospital, 3426-3 Anegasaki, Ichihara, Chiba 299-0111, Japan.

Medical Electron Microscopy : Official Journal of the Clinical Electron Microscopy Society of Japan
|September 28, 2004
PubMed

Insights

Antisense oligodeoxynucleotides can suppress gene expression to inhibit glioma cell growth. This gene silencing approach offers a promising new avenue for antitumor therapy in gliomas.

Area of Science:

  • Molecular biology
  • Genetics
  • Oncology

Background:

  • Antisense oligodeoxynucleotides (ODNs) are synthetic DNA molecules designed to bind to specific messenger RNA (mRNA) sequences.
  • This binding inhibits protein synthesis, offering a method for targeted gene silencing.
  • Gliomas are aggressive brain tumors with limited treatment options.

Purpose of the Study:

  • To explore the application of antisense strategy for suppressing gene expression in glioma cells.
  • To evaluate the potential of antisense ODNs as a novel antitumor therapy for gliomas.

Main Methods:

  • Utilizing synthetic oligodeoxynucleotides to target specific genes involved in glioma proliferation.
  • Applying antisense strategy to modulate gene expression within glioma cells.
  • Assessing the impact of gene suppression on glioma cell growth.

Main Results:

  • Antisense strategy effectively suppressed the expression of several key genes in glioma cells.
  • Targeted genes included growth factors (transforming growth factor-alpha, vascular endothelial growth factor), growth factor receptors (fibroblast growth factor receptor 1), and enzymes crucial for cell division (telomerase, topoisomerase II alpha-subunit).
  • Other targeted genes involved in cell signaling and structure (protein kinase C-alpha, microtubule-associated protein 1A) were also modulated.

Conclusions:

  • Antisense strategy is a viable approach for the growth suppression of glioma cells.
  • Targeting specific genes involved in glioma development holds promise for novel antitumor therapies.
  • Further research into antisense ODNs could lead to new treatment modalities for gliomas.

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...